Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitamin B12, also known as cobalamin, is an essential water-soluble vitamin that plays a critical role in DNA synthesis, methylation, and mitochondrial metabolism. It serves as a vital cofactor for enzymes such as methionine synthase and methylmalonyl-CoA mutase, which are necessary for the maintenance of the central nervous system and the formation of the myelin sheath. In the provided clinical context, Vitamin B12 is being investigated as a component of Stellate Ganglion Block (SGB) therapy, typically administered in combination with local anesthetics like lidocaine. This therapeutic approach is being evaluated for its efficacy in treating functional and neurological impairments, including dysphagia, cognitive impairment, and drooling in patients with Cerebral Small Vessel Disease (CSVD), traumatic brain injury, and Parkinson's syndrome. The rationale for its use in these procedures involves its potential neuroprotective and nerve-regenerative properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin b12.